Tectonic Therapeutic | AVRO - Selling And Administration Expenses


Tectonic Therapeutic reported $4.96M in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Alnylam Pharmaceuticals USD 262.59M 60.72M Sep/2025
Celltrion KRW 249.98B 16.36B Sep/2025
Cspc Pharmaceutical CNY 1.97B 404.66M Sep/2025
Dianthus Therapeutics USD 8.2M 669K Sep/2025
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Gilead Sciences USD 1.35B 6M Sep/2025
Ionis Pharmaceuticals USD 86.56M 4.04M Sep/2025
Kangmei Pharma CNY 274.41M 15.05M Sep/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
MacroGenics USD 9.9M 600K Sep/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 7.03M 5.91M Jun/2025
Neuren Pharmaceuticals AUD 1.24M 1.09M Jun/2025
Organigram Holdings CAD 8.86M 499K Sep/2025
Pfizer USD 3.19B 209M Sep/2025
Pharma Mar EUR 13.7M 983K Sep/2025
Qiagen NV USD 143.11M 5.64M Sep/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Sarepta Therapeutics USD 77.11M 7.22M Sep/2025
Sartorius EUR 218.7M 6.5M Sep/2025
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Takeda JPY 282.78B 29.23B Dec/2025
Tilray USD 24.85M 1.7M Sep/2025
Zz Pientze Pharmaceu CNY 171.91M 343.2M Sep/2025